Probable Warfarin–Simvastatin Interaction

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Annals of Pharmacotherapy

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1345/aph.1K167PMID 17565042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Switching statins in Norway after new reimbursement policy: a nationwide prescription study.

  2007cited by this paper
• The impact of simvastatin on warfarin disposition and dose requirements

  2006cited by this paper
• Effects of Acid and Lactone Forms of Eight HMG-CoA Reductase Inhibitors on CYP-Mediated Metabolism and MDR1-Mediated Transport

  2005cited by this paper
• Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.

  2005cited by this paper
• CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: A HuGEnet™ systematic review and meta-analysis

  2005cited by this paper
• Comparative Pharmacokinetics of Vitamin K Antagonists

  2005cited by this paper
• Oral Anticoagulant Drug Interactions with Statins: Case Report of Fluvastatin and Review of the Literature

  2004cited by this paper
• The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements

  2003cited by this paper
• The Effect of Converting from Pravastatin to Simvastatin on the Pharmacodynamics of Warfarin

  1999cited by this paper
• Potential Warfarin—Fluvastatin Interaction

  1997cited by this paper
• Atorvastatin Does Not Alter the Anticoagulant Activity of Warfarin

  1997cited by this paper
• Potential Interaction between Warfarin and Fluvastatin

  1996cited by this paper
• Simvastatin-oral anticoagulant interaction.

  1996cited by this paper
• In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

  1996cited by this paper
• Lovastatin during warfarin therapy resulting in bleeding.

  1995cited by this paper
• The interaction of lovastatin and warfarin.

  1992cited by this paper
• The interaction of lovastatin and warfarin.

  1992cited by this paper
• Metabolic enantiomeric interactions: the inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin.

  1991cited by this paper
• Lovastatin. Warfarin interaction.

  1990cited by this paper
• A method for estimating the probability of adverse drug reactions

  1981cited by this paper

• Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism—From Modern Recommendations to Clinical Application

  2022cites this paper
• Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3).

  2020cites this paper
• Drug Interactions in Elderly People Making use of oral Anticoagulants and Hospitalized in a Cardiology Hospital / Interações Medicamentosas nos Idosos em uso de Anticoagulantes Orais Internados num Hospital Cardiológico

  2019cites this paper
• Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record

  2018cites this paper
• Drug-drug interactions of warfarin and new direct oral anticoagulans

  2018cites this paper
• Statins do not Increase the Rate of Bleeding Among Warfarin Users

  2018cites this paper
• Lékové interakce warfarinu a nových, přímých orálních antikoagulancií

  2018cites this paper
• Old and new oral anticoagulants: Food, herbal medicines and drug interactions.

  2017cites this paper
• To attach or not to attach : factors behind variable adhesion properties of cryopreserved human hepatocytes

  2016cites this paper
• Mechanism of Drug-Drug Interactions Between Warfarin and Statins.

  2016cites this paper
• Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

  2016cites this paper
• Review of Top 10 Prescribed Drugs and Their Interaction with Dental Treatment.

  2016cites this paper
• Identifying Drug–Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions

  2016cites this paper
• Nontraumatic Retroperitoneal Hematoma After Warfarin Administration: Fatal Case Report and Review of the Literature.

  2015cites this paper
• Aortic Atherosclerosis as an Embolic Source

  2015cites this paper
• Potential statin-drug interactions: prevalence and clinical significance

  2014cites this paper
• Drug interactions with statins

  2013cites this paper
• Towards optimal dosing of coumarin derivatives: the role of pharmacogenetics

  2013cites this paper
• Genetic Bleeding Risk Score (GBRS) for Patients on Oral Anticoagulant Therapy

  2013cites this paper
• Hemarthrosis in a Patient on Warfarin Receiving Ceftaroline: A Case Report and Brief Review of Cephalosporin Interactions with Warfarin

  2012cites this paper
• Perceval sutureless approach in a patient with porcelain aorta unsuitable for transcatheter aortic valve implantation.

  2012cites this paper
• Common Drug Interactions Leading to Adverse Drug Events in the ICU : Management and Pharmacokinetic Considerations

  2012cites this paper
• Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more

  2012cites this paper
• Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose

  2012cites this paper
• ROLE OF CLINICAL PHARMACIST IN ANTICOAGULATION MANAGEMENT

  2012cites this paper
• The interaction between fluvastatin and warfarin.

  2012cites this paper
• Simvastatin interactions with other drugs

  2012cites this paper
• Statin Drug Interactions in Patients with Comorbidities and on Multiple Medications

  2012cites this paper
• Drug Interactions Involving Warfarin: Practice Tool and Practical Management Tips

  2011cites this paper
• Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry.

  2011cites this paper
• Drug and dietary interactions of warfarin and novel oral anticoagulants: an update

  2011cites this paper
• Effect of atorvastatin on CYP2C9 metabolic activity as measured by the formation rate of losartan metabolite in hypercholesterolaemic patients.

  2011cites this paper
• Strategies for Treating Abnormal Lipid Profiles with Drugs

  2011cites this paper
• Influência de polimorfismos nos genes PROC e F7 na dose terapêutica da varfarina

  2010cites this paper
• Farmacogenética da varfarina : proposta de um algoritmo para a predição de dose

  2010cites this paper
• 44 - Drugs that affect lipid metabolism

  2010cites this paper
• Drugs that affect blood coagulation, fibrinolysis, and hemostasis

  2010cites this paper
• Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients

  2010cites this paper
• Evidence-Based Guidelines for Cardiovascular Risk Reduction: The Safety and Efficacy of High-Dose Statin Therapy

  2009cites this paper
• Leczenie dużymi dawkami statyn: korzyści i bezpieczeństwo intensywnej terapii

  2009cites this paper
• Interaction Between Gemfibrozil and Warfarin: Case Report and Review of the Literature

  2009cites this paper
• Statins and stroke.

  2008cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2008cites this paper